BOCA RATON, Fla.–(BUSINESS WIRE)–November 21, 2013–
Zero Gravity Solutions, Inc. (ZGSI or “the Company”), (Pink Sheets: ZGSI), announced today the appointment of former Congressman Robert S. Walker as Legislative and Regulatory Advisor. Congressman Walker has been a leading voice in Congress as to the funding and value of the United States Space Program and the International Space Station in particular as Chairman of the House Committee on Science and Technology. Mr. Walker has served on the President’s Commission on Implementation of United States Space Exploration Policy and on the President’s Commission on the Future of the United States Aerospace Industry.
Harvey Kaye, Chairman of the Company, stated, “Bob has been on the forefront in setting policy for the future direction of our nation’s space program. He is exceptionally qualified to assist our company with monitoring the political dynamics which relate to ZGSI’s business as well as develop and nurture key relationships within the legislative and regulatory communities.”
Richard Godwin, Chief Executive Officer and President of ZGSI, stated, “I have been involved for more than 20 years with various aspects of the potential to commercialize Low Earth Orbit and the ISS, including recent work with Elon Musk and SpaceX. I have had the opportunity to see first-hand Bob’s unwavering commitment to the nation’s human space program and also the intellectual firepower he brings to our company.”
Mr. Walker, ZGSI’s newly appointed Legislative and Regulatory Advisor, stated, “I am delighted to become a part of the ZGSI team. When the International Space Station was created, our dream was to produce world class science that would lead to remarkable new products for all of humankind. ZGSI is in the forefront of making that dream a reality, and I hope my experience in government policy will help grow a company that is focused on the future.”
About Zero Gravity Solutions, Inc.
Zero Gravity Solutions, Inc. is a zero gravity biotechnology company whose mission is to improve life on earth by using technology designed for and derived from space and through utilization of the unique long-term microgravity environment platform of the International Space Station (ISS). The Company’s initial projects will be directed to providing solutions to critical world food crops challenges. The Company owns proprietary technology for its first commercial product, BAM-FX™ that can boost the nutritional value and enhance the immune system of food crops without the use of Genetic Modification. Further, the Company is focused on industrializing and commercializing scientific breakthroughs in the area of patentable stem cell technologies through developing advances in plant, animal and human biology based on intellectual property designed for and derived from multiple experiments on the ISS. The Company owns intellectual property that is designed to develop and produce, in a microgravity environment and without Genetic Modification techniques, large volumes of novel stem cells with unique and beneficial characteristics, which can be patented for commercial sale to third parties in the agricultural and human regenerative medical markets. ZGSI is headquartered in Boca Raton, Florida with offices and/or operations in Naperville, Illinois and Stevensville, Maryland. Information on the Company can be viewed on www.zerogsi.com.
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission.